In mouse trials, a vaccine based on recombinant adenovirus protected against Zika without evidence of antibodies. Reports have shown Zika antibodies can worsen Dengue virus infection.
Virologists discover safer potential Zika vaccine
In mouse trials, a vaccine based on recombinant adenovirus protected against Zika without evidence of antibodies. Reports have shown Zika antibodies can worsen Dengue virus infection.